Search

everythinglearnresearchcommunity

for

Search:↓

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Both mouse and rat models are effective for testing alopecia areata treatments.

Testosterone may slow down wound healing and increase inflammation.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.